Cargando…

Cytokine Response in SARS-CoV-2 Infection in the Elderly

The last few months of 2019 witnessed the emergence, rise and rapid spread of a novel coronavirus known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing an acute respiratory disease called coronavirus disease 2019 or Covid-19. Severe pathological manifestations of the disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sherwani, Subuhi, Khan, Mohd Wajid Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585778/ https://www.ncbi.nlm.nih.gov/pubmed/33116752 http://dx.doi.org/10.2147/JIR.S276091

Ejemplares similares

Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD)
por: Sherwani, Subuhi, et al.
Publicado: (2022)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Cytokine Response to SARS-CoV-2 Infection in Children
por: Curatola, Antonietta, et al.
Publicado: (2021)

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
por: Pum, Alexandra, et al.
Publicado: (2021)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Melatonin and Cytokines Modulate Daily Instrumental Activities of Elderly People with SARS-CoV-2 Infection
por: França, Danielle Cristina Honorio, et al.
Publicado: (2023)

Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA
por: Sherwani, Subuhi, et al.
Publicado: (2022)

Directional preference for glioblastoma cancer cell membrane encapsulated nanoparticle population: A probabilistic approach for cancer therapeutics
por: Khan, Saif, et al.
Publicado: (2023)

Hematopoietic responses to SARS-CoV-2 infection
por: Elahi, Shokrollah
Publicado: (2022)

SARS-CoV-2 infection and immune responses
por: Harne, Rakhi, et al.
Publicado: (2023)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
por: Ciabattini, Annalisa, et al.
Publicado: (2020)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Insights into Multifunctional Nanoparticle-Based Drug Delivery Systems for Glioblastoma Treatment
por: Khan, Mohd, et al.
Publicado: (2021)

Daytime variation in SARS-CoV-2 infection and cytokine production
por: Diallo, Aïssatou Bailo, et al.
Publicado: (2021)

SARS-CoV-2 Induces Cytokine Responses in Human Basophils
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2022)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection
por: Campana, Pasquale, et al.
Publicado: (2021)

Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2
por: Abbas, Heba Salah, et al.
Publicado: (2023)

Glycation and Oxidative Stress Increase Autoantibodies in the Elderly
por: Khan, Mohd W.A., et al.
Publicado: (2020)

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations
por: Thepmankorn, Parisorn, et al.
Publicado: (2021)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
por: Oves, Mohammad, et al.
Publicado: (2020)

Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells
por: Hafezi, Bahareh, et al.
Publicado: (2021)

The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm
por: Zimecki, Michał, et al.
Publicado: (2021)

Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction
por: Ahmad, Rahnuma, et al.
Publicado: (2022)

SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis
por: Pedreañez, Adriana, et al.
Publicado: (2021)

Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges
por: Ali, Fares E M, et al.
Publicado: (2021)

Cytokine storm induced by SARS-CoV-2
por: Song, Peipei, et al.
Publicado: (2020)

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
por: Hemmat, Nima, et al.
Publicado: (2021)

SARS-CoV-2 Infection and the Liver
por: Morgan, Katie, et al.
Publicado: (2020)

Inflammasomes and SARS-CoV-2 Infection
por: Kaivola, Juha, et al.
Publicado: (2021)

Neuroimmunoendocrinology of SARS-CoV-2 Infection
por: Bellastella, Giuseppe, et al.
Publicado: (2022)

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
por: Costela-Ruiz, Víctor J., et al.
Publicado: (2020)

Insights into how SARS-CoV2 infection induces cytokine storms
por: Selva, Kevin John, et al.
Publicado: (2022)

Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
por: Puhl, Ana C., et al.
Publicado: (2022)

A proteomic perspective and involvement of cytokines in SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2023)

SARS‐CoV‐2 and lung injury: Dysregulation of immune response but not hyperimmune response as in “cytokine storm syndrome”
por: Öcal, Serpil
Publicado: (2021)

Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions
por: Noroozi, Rezvan, et al.
Publicado: (2020)

Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
por: Chen, Jennifer S., et al.
Publicado: (2021)

Neuropathogenesis of SARS-CoV-2 infection
por: Khan, Shumayila, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3foda5p392qk09o9b7hkg7s4ds